Roquefort Therapeutics PLC - London-based biotechnology company - Says it has opted against a fundraise following ‘unusual share price movements’. The company had engaged advisers to commence ‘market soundings’ in relation to a potential placing, but says that ‘incorrect bulletin board comments regarding a speculative placing price,’ which in turn impacted its share price, turned it against the idea. Shares in Roquefort dropped 36% on Thursday from 6.89 pence each to 4.41 pence, having hovered around the 7p mark for the whole of March.

Current stock price: 4.18 pence per share, down 7.0% in London on Friday

12-month change: down 39%

Copyright 2024 Alliance News Ltd. All Rights Reserved.